切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (05) : 345 -349. doi: 10.3877/cma.j.issn.2095-3232.2018.05.001

所属专题: 文献

述评

肝切除术后肝衰竭早期诊断及预防
蒋贝格1, 周伟平1,()   
  1. 1. 200438 上海,海军军医大学附属东方肝胆外科医院肝外三科
  • 收稿日期:2018-07-11 出版日期:2018-10-10
  • 通信作者: 周伟平
  • 基金资助:
    传染病十三五重大专项(2017ZX10203208); 国家自然基金创新团体(81521091)

Early diagnosis and prevention of liver failure after hepatectomy

Beige Jiang1, Weiping Zhou1()   

  • Received:2018-07-11 Published:2018-10-10
  • Corresponding author: Weiping Zhou
引用本文:

蒋贝格, 周伟平. 肝切除术后肝衰竭早期诊断及预防[J]. 中华肝脏外科手术学电子杂志, 2018, 07(05): 345-349.

Beige Jiang, Weiping Zhou. Early diagnosis and prevention of liver failure after hepatectomy[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(05): 345-349.

表1 ISGLS PHLF分级标准[2]
[1]
Russell MC. Complications following hepatectomy[J]. Surg Oncol Clin N Am, 2015, 24(1):73-96.
[2]
Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS)[J]. Surgery, 2011, 149(5):713-724.
[3]
Zheng Y, Yang H, He L, et al. Reassessment of different criteria for diagnosing post-hepatectomy liver failure: a single-center study of 1683 hepatectomy[J]. Oncotarget, 2017, 8(51):89269-89277.
[4]
Chuang YH, Ou HY, Lazo MZ, et al. Predicting post-hepatectomy liver failure by combined volumetric, functional MR image and laboratory analysis[J]. Liver Int, 2018, 38(5):868-874.
[5]
van den Broek MA, Olde Damink SW, Dejong CH, et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment[J]. Liver Int, 2008, 28(6):767-780.
[6]
Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4):864-871.
[7]
Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2):464-470.
[8]
Qadan M, Garden OJ, Corvera CU, et al. Management of postoperative hepatic failure[J]. J Am Coll Surg, 2016, 222(2):195-208.
[9]
Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy[J]. Ann Surg, 2005, 242(6):824-828.
[10]
Reissfelder C, Rahbari NN, Koch M, et al. Postoperative course and clinical significance of biochemical blood tests following hepatic resection[J]. Br J Surg, 2011, 98(6):836-844.
[11]
Kauffmann R, Fong Y. Post-hepatectomy liver failure[J]. Hepatobiliary Surg Nutr, 2014, 3(5):238-246.
[12]
Ross SW, Seshadri R, Walters AL, et al. Mortality in hepatectomy: model for end-stage liver disease as a predictor of death using the National Surgical Quality Improvement Program database[J]. Surgery, 2016, 159(3):777-792.
[13]
Wagener G. Assessment of hepatic function, operative candidacy, and medical management after liver resection in the patient with underlying liver disease[J]. Semin Liver Dis, 2013, 33(3):204-212.
[14]
Vauthey JN, Dixon E, Abdalla EK, et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement[J]. HPB, 2010, 12(5):289-299.
[15]
Narita M, Oussoultzoglou E, Bachellier P, et al. Post-hepatectomy liver failure in patients with colorectal liver metastases[J]. Surg Today, 2015, 45(10):1218-1226.
[16]
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012, 255(3):405-414.
[17]
Imamura H, Sano K, Sugawara Y, et al. Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test[J]. J Hepatobiliary Pancreat Surg, 2005, 12(1):16-22.
[18]
Chu CM, Chen YC, Tai DI, et al. Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase[J]. Clin Gastroenterol Hepatol, 2010, 8(6):535-540.
[19]
Huang G, Lai EC, Lau WY, et al. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels[J]. Ann Surg, 2013, 257(3):490-505.
[20]
Yamazaki O, Matsuyama M, Horii K, et al. Comparison of the outcomes between anatomical resection and limited resection for single hepatocellular carcinomas no larger than 5 cm in diameter: a single-center study[J]. J Hepatobiliary Pancreat Sci, 2010, 17(3): 349-358.
[21]
Nanashima A, Sumida Y, Abo T, et al. Comparison of survival between anatomic and non-anatomic liver resection in patients with hepatocellular carcinoma: significance of surgical margin in non-anatomic resection[J]. Acta Chir Belg, 2008, 108(5):532-537.
[22]
邓国荣,陈博艺,李荣,等.术前血小板淋巴细胞比率对肝细胞癌患者的临床意义分析[J/CD].中华普通外科学文献(电子版),2017, 11(1):13-17.
[23]
Alkozai EM, Nijsten MW, de Jong KP, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection[J]. Ann Surg, 2010, 251(2):300-306.
[24]
张军,许建伟,殷凯,等.肝癌肝部分切除术后患者血小板计数与肝功能恢复的相关性研究[J].肝胆胰外科杂志,2012, 24(5): 359-361.
[25]
Otsuka Y, Duffy JP, Saab S, et al. Postresection hepatic failure: successful treatment with liver transplantation[J]. Liver Transpl, 2007, 13(5):672-679.
[1] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[2] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[3] 汤海琴, 郭秀枝, 朱晓素, 赵世娣. “隧道法”腹腔镜解剖性左半肝切除术的临床安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 674-677.
[4] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[5] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[6] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[7] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[8] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[9] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[10] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[11] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[12] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[13] 陈安, 冯娟, 杨振宇, 杜锡林, 柏强善, 阴继凯, 臧莉, 鲁建国. 基于生物信息学分析CCN4在肝细胞癌中表达及其临床意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 702-707.
[14] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[15] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
阅读次数
全文


摘要